Literature DB >> 17613776

Efficacy of bortezomib in combination chemotherapy on secondary plasma cell leukemia.

Ridvan Ali, Meral Beksac, Fahir Ozkalemkas, Vildan Ozkocaman, Atilla Ozkan, Tulay Ozcelik, Ahmet Tunali.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17613776     DOI： 10.1080/10428190701370597

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  4 in total

1.  A case of secondary plasma cell leukemia resistant to novel agents, in which stringent complete remission was achieved and maintained for a long period of time after VAD therapy and tandem autologous transplantation.

Authors:  Yasunobu Sekiguchi; Asami Shimada; Mutsumi Wakabayashi; Keiji Sugimoto; Shigeki Tomita; Hiroshi Izumi; Noriko Nakamura; Tomohiro Sawada; Yasunori Ohta; Norio Komatsu; Masaaki Noguchi
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

Review 2.  Plasma cell leukaemia and other aggressive plasma cell malignancies.

Authors:  Taimur Sher; Kena C Miller; George Deeb; Kelvin Lee; Asher Chanan-Khan
Journal:  Br J Haematol       Date:  2010-08       Impact factor: 6.998

Review 3.  Primary Plasma Cell Leukemia: Identity Card 2016.

Authors:  Pellegrino Musto; Vittorio Simeon; Katia Todoerti; Antonino Neri
Journal:  Curr Treat Options Oncol       Date:  2016-04

4.  Bortezomib-based Regimens Improve the Outcome of Patients with Primary or Secondary Plasma Cell Leukemia: A Retrospective Cohort Study

Authors:  Huijuan Wang; Huixing Zhou; Zhiyao Zhang; Chuanying Geng; Wenming Chen
Journal:  Turk J Haematol       Date:  2019-11-26       Impact factor: 1.831
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.